ADAMTS9 and gastric cancer: Another deep impressed study demonstrated that lncRNA ADAMTS9-AS2 impeded GC progression and decreased the tumorigenicity of cancer stem cells through regulating SPOP, which may provide a novel target in the treatment of GC (88).